A detailed history of Empery Asset Management, LP transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Empery Asset Management, LP holds 308,466 shares of SLS stock, worth $416,429. This represents 3.71% of its overall portfolio holdings.

Number of Shares
308,466
Previous 927,984 66.76%
Holding current value
$416,429
Previous $2.07 Million 69.89%
% of portfolio
3.71%
Previous 11.2%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$2.02 - $3.38 $1.25 Million - $2.09 Million
-619,518 Reduced 66.76%
308,466 $623,000
Q2 2022

Aug 12, 2022

BUY
$2.14 - $4.15 $1.99 Million - $3.85 Million
927,984 New
927,984 $2.07 Million

Others Institutions Holding SLS

About SELLAS Life Sciences Group, Inc.


  • Ticker SLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,551,900
  • Market Cap $27.7M
  • Description
  • SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...
More about SLS
Track This Portfolio

Track Empery Asset Management, LP Portfolio

Follow Empery Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empery Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Empery Asset Management, LP with notifications on news.